Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

COL4A2 is associated with lacunar ischemic stroke and deep ICH: Meta-analyses among 21,500 cases and 40,600 controls.

Rannikmäe K, Sivakumaran V, Millar H, Malik R, Anderson CD, Chong M, Dave T, Falcone GJ, Fernandez-Cadenas I, Jimenez-Conde J, Lindgren A, Montaner J, O'Donnell M, Paré G, Radmanesh F, Rost NS, Slowik A, Söderholm M, Traylor M, Pulit SL, Seshadri S, Worrall BB, Woo D, Markus HS, Mitchell BD, Dichgans M, Rosand J, Sudlow CLM; Stroke Genetics Network (SiGN), METASTROKE Collaboration, and International Stroke Genetics Consortium (ISGC).

Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004560. doi: 10.1212/WNL.0000000000004560. [Epub ahead of print]

PMID:
28954878
2.

Association of the PLCB1 gene with drug dependence.

Cabana-Domínguez J, Roncero C, Pineda-Cirera L, Palma-Álvarez RF, Ros-Cucurull E, Grau-López L, Esojo A, Casas M, Arenas C, Ramos-Quiroga JA, Ribasés M, Fernàndez-Castillo N, Cormand B.

Sci Rep. 2017 Aug 31;7(1):10110. doi: 10.1038/s41598-017-10207-2.

3.

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder.

Garcia-Martínez I, Sánchez-Mora C, Soler Artigas M, Rovira P, Pagerols M, Corrales M, Calvo-Sánchez E, Richarte V, Bustamante M, Sunyer J, Cormand B, Casas M, Ramos-Quiroga JA, Ribasés M.

Sci Rep. 2017 Jul 14;7(1):5407. doi: 10.1038/s41598-017-05514-7.

4.

SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.

Merker S, Reif A, Ziegler GC, Weber H, Mayer U, Ehlis AC, Conzelmann A, Johansson S, Müller-Reible C, Nanda I, Haaf T, Ullmann R, Romanos M, Fallgatter AJ, Pauli P, Strekalova T, Jansch C, Vasquez AA, Haavik J, Ribasés M, Ramos-Quiroga JA, Buitelaar JK, Franke B, Lesch KP.

J Child Psychol Psychiatry. 2017 Jul;58(7):798-809. doi: 10.1111/jcpp.12702. Epub 2017 Feb 22.

PMID:
28224622
5.

Exome chip analyses in adult attention deficit hyperactivity disorder.

Zayats T, Jacobsen KK, Kleppe R, Jacob CP, Kittel-Schneider S, Ribasés M, Ramos-Quiroga JA, Richarte V, Casas M, Mota NR, Grevet EH, Klein M, Corominas J, Bralten J, Galesloot T, Vasquez AA, Herms S, Forstner AJ, Larsson H, Breen G, Asherson P, Gross-Lesch S, Lesch KP, Cichon S, Gabrielsen MB, Holmen OL, Bau CH, Buitelaar J, Kiemeney L, Faraone SV, Cormand B, Franke B, Reif A, Haavik J, Johansson S.

Transl Psychiatry. 2016 Oct 18;6(10):e923. doi: 10.1038/tp.2016.196.

6.

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder.

Garcia-Martínez I, Sánchez-Mora C, Pagerols M, Richarte V, Corrales M, Fadeuilhe C, Cormand B, Casas M, Ramos-Quiroga JA, Ribasés M.

Transl Psychiatry. 2016 Aug 30;6(8):e879. doi: 10.1038/tp.2016.151.

7.

A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence.

Cabana-Domínguez J, Roncero C, Grau-López L, Rodríguez-Cintas L, Barral C, Abad AC, Erikson G, Wineinger NE, Torrico B, Arenas C, Casas M, Ribasés M, Cormand B, Fernàndez-Castillo N.

Sci Rep. 2016 Aug 8;6:31033. doi: 10.1038/srep31033.

8.

Lack of replication of previous autism spectrum disorder GWAS hits in European populations.

Torrico B, Chiocchetti AG, Bacchelli E, Trabetti E, Hervás A, Franke B, Buitelaar JK, Rommelse N, Yousaf A, Duketis E, Freitag CM, Caballero-Andaluz R, Martinez-Mir A, Scholl FG, Ribasés M; ITAN, Battaglia A, Malerba G, Delorme R, Benabou M, Maestrini E, Bourgeron T, Cormand B, Toma C.

Autism Res. 2017 Feb;10(2):202-211. doi: 10.1002/aur.1662. Epub 2016 Jul 15.

PMID:
27417655
9.

Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.

Stringer S, Minică CC, Verweij KJ, Mbarek H, Bernard M, Derringer J, van Eijk KR, Isen JD, Loukola A, Maciejewski DF, Mihailov E, van der Most PJ, Sánchez-Mora C, Roos L, Sherva R, Walters R, Ware JJ, Abdellaoui A, Bigdeli TB, Branje SJ, Brown SA, Bruinenberg M, Casas M, Esko T, Garcia-Martinez I, Gordon SD, Harris JM, Hartman CA, Henders AK, Heath AC, Hickie IB, Hickman M, Hopfer CJ, Hottenga JJ, Huizink AC, Irons DE, Kahn RS, Korhonen T, Kranzler HR, Krauter K, van Lier PA, Lubke GH, Madden PA, Mägi R, McGue MK, Medland SE, Meeus WH, Miller MB, Montgomery GW, Nivard MG, Nolte IM, Oldehinkel AJ, Pausova Z, Qaiser B, Quaye L, Ramos-Quiroga JA, Richarte V, Rose RJ, Shin J, Stallings MC, Stiby AI, Wall TL, Wright MJ, Koot HM, Paus T, Hewitt JK, Ribasés M, Kaprio J, Boks MP, Snieder H, Spector T, Munafò MR, Metspalu A, Gelernter J, Boomsma DI, Iacono WG, Martin NG, Gillespie NA, Derks EM, Vink JM.

Transl Psychiatry. 2016 Mar 29;6:e769. doi: 10.1038/tp.2016.36.

10.

Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder.

Brevik EJ, van Donkelaar MM, Weber H, Sánchez-Mora C, Jacob C, Rivero O, Kittel-Schneider S, Garcia-Martínez I, Aebi M, van Hulzen K, Cormand B, Ramos-Quiroga JA; IMAGE Consortium, Lesch KP, Reif A, Ribasés M, Franke B, Posserud MB, Johansson S, Lundervold AJ, Haavik J, Zayats T.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jul;171(5):733-47. doi: 10.1002/ajmg.b.32434. Epub 2016 Mar 29.

11.

Connecting the dots, genome-wide association studies in substance use.

Nivard MG, Verweij KJ, Minică CC, Treur JL; International Cannabis Consortium, Vink JM, Boomsma DI.

Mol Psychiatry. 2016 Jun;21(6):733-5. doi: 10.1038/mp.2016.14. Epub 2016 Mar 15. No abstract available.

PMID:
26976040
12.

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

Pagerols M, Richarte V, Sánchez-Mora C, Garcia-Martínez I, Corrales M, Corominas M, Cormand B, Casas M, Ribasés M, Ramos-Quiroga JA.

Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.

PMID:
26810137
13.

Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study.

NINDS Stroke Genetics Network (SiGN); International Stroke Genetics Consortium (ISGC).

Lancet Neurol. 2016 Feb;15(2):174-184. doi: 10.1016/S1474-4422(15)00338-5. Epub 2015 Dec 19.

14.

Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence.

Fernàndez-Castillo N, Cabana-Domínguez J, Soriano J, Sànchez-Mora C, Roncero C, Grau-López L, Ros-Cucurull E, Daigre C, van Donkelaar MM, Franke B, Casas M, Ribasés M, Cormand B.

Transl Psychiatry. 2015 Oct 27;5:e667. doi: 10.1038/tp.2015.158.

15.

An exploratory association study of the influence of noradrenergic genes and childhood trauma in Borderline Personality Disorder.

Martín-Blanco A, Ferrer M, Soler J, Arranz MJ, Vega D, Bauzà J, Calvo N, Elices M, Sanchez-Mora C, García-Martinez I, Salazar J, Ribases M, Carmona C, Prat M, Pascual JC.

Psychiatry Res. 2015 Sep 30;229(1-2):589-92. doi: 10.1016/j.psychres.2015.07.046. Epub 2015 Jul 21.

PMID:
26216165
16.

New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder.

Alemany S, Ribasés M, Vilor-Tejedor N, Bustamante M, Sánchez-Mora C, Bosch R, Richarte V, Cormand B, Casas M, Ramos-Quiroga JA, Sunyer J.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):459-470. doi: 10.1002/ajmg.b.32341. Epub 2015 Jul 14.

PMID:
26174813
17.

Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.

Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. Epub 2015 Jul 14.

PMID:
26174753
18.

On the role of NOS1 ex1f-VNTR in ADHD-allelic, subgroup, and meta-analysis.

Weber H, Kittel-Schneider S, Heupel J, Weißflog L, Kent L, Freudenberg F, Alttoa A, Post A, Herterich S, Haavik J, Halmøy A, Fasmer OB, Landaas ET, Johansson S, Cormand B, Ribasés M, Sánchez-Mora C, Ramos-Quiroga JA, Franke B, Lesch KP, Reif A.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):445-458. doi: 10.1002/ajmg.b.32326. Epub 2015 Jun 18.

PMID:
26086921
19.

Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.

Maier R, Moser G, Chen GB, Ripke S; Cross-Disorder Working Group of the Psychiatric Genomics Consortium, Coryell W, Potash JB, Scheftner WA, Shi J, Weissman MM, Hultman CM, Landén M, Levinson DF, Kendler KS, Smoller JW, Wray NR, Lee SH.

Am J Hum Genet. 2015 Feb 5;96(2):283-94. doi: 10.1016/j.ajhg.2014.12.006. Epub 2015 Jan 29.

20.

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways.

Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium.

Nat Neurosci. 2015 Feb;18(2):199-209. doi: 10.1038/nn.3922. Epub 2015 Jan 19. Erratum in: Nat Neurosci. 2015 Jun;18(6):926. Nat Neurosci. 2015 Dec;18(12):1861.

Supplemental Content

Loading ...
Support Center